We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

46 hedge funds and large institutions have $111M invested in ProQR Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

10% more funds holding

Funds holding: 42 → 46 (+4)

3.19% less ownership

Funds ownership: 55.87% → 52.68% (-3.2%)

17% less capital invested

Capital invested by funds: $134M → $111M (-$23.3M)

43% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 14

97% less call options, than puts

Call options by funds: $2K | Put options by funds: $71K

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
46
Holders Change
+4
Holders Change %
+9.52%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
8
Reduced
14
Closed
10
Calls
$2K
Puts
$71K
Net Calls
-$69K
Net Calls Change
-$74K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$3.37M
2
KA
Kerrisdale Advisers
Florida
+$1.91M
3
JP Morgan Chase
JP Morgan Chase
New York
+$1.2M
4
PM
Prosight Management
Texas
+$1.08M
5
Renaissance Technologies
Renaissance Technologies
New York
+$820K

Top Sellers

Rank Fund Capital Flow
1
ACM
Aquilo Capital Management
California
-$10.9M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$5.34M
3
BlackRock
BlackRock
New York
-$1.93M
4
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$193K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$191K
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$21M +$154K +36,594 +0.7%
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$19.1M – – –
Wellington Management Group
3
Wellington Management Group
Massachusetts
$14.5M -$5.34M -1,266,475 -27%
Goldman Sachs
4
Goldman Sachs
New York
$13.8M -$109K -25,802 -0.8%
Jennison Associates
5
Jennison Associates
New York
$11M -$74.5K -17,667 -0.7%
DCM
6
DAFNA Capital Management
California
$5.2M – – –
AG
7
Artal Group
Luxembourg
$5.02M – – –
Morgan Stanley
8
Morgan Stanley
New York
$4.26M +$3.37M +798,966 +371%
JP Morgan Chase
9
JP Morgan Chase
New York
$2.54M +$1.2M +284,605 +89%
UBS Group
10
UBS Group
Switzerland
$1.98M -$26.3K -6,222 -1%
KA
11
Kerrisdale Advisers
Florida
$1.9M +$1.91M +453,182 New
Renaissance Technologies
12
Renaissance Technologies
New York
$1.41M +$820K +194,300 +138%
Fidelity International
13
Fidelity International
Bermuda
$1.39M – – –
CAC
14
Cowen and Company
New York
$1.2M -$52K -12,326 -4%
PM
15
Prosight Management
Texas
$1.07M +$1.08M +255,000 New
AGA
16
Altrinsic Global Advisors
Connecticut
$1.01M +$84.4K +20,000 +9%
Millennium Management
17
Millennium Management
New York
$764K +$767K +181,883 New
Deutsche Bank
18
Deutsche Bank
Germany
$760K +$763K +180,927 New
Fidelity Investments
19
Fidelity Investments
Massachusetts
$422K -$108K -25,500 -20%
California Public Employees Retirement System
20
California Public Employees Retirement System
California
$392K -$8.44K -2,000 -2%
AA
21
ALPS Advisors
Colorado
$376K +$108K +25,615 +40%
FSA
22
Franklin Street Advisors
North Carolina
$252K – – –
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$221K -$2.32K -550 -1%
GCP
24
GSA Capital Partners
United Kingdom
$200K +$201K +47,625 New
Two Sigma Investments
25
Two Sigma Investments
New York
$166K +$167K +39,475 New
1
2 3

PRQR Hedge Fund Activity: Q4 2020 in Review

46 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q4 2020, worth a combined $111M — down 17% from $134M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new PRQR positions and 10 closed out — a net gain of 4 holders — while 8 added to existing stakes and 14 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $3.37M. The largest seller was Aquilo Capital Management, exiting entirely with an estimated $10.9M sold.

  • 46 institutional investors held ProQR Therapeutics (PRQR) as of Q4 2020, up from 42 in Q3 2020.
  • Funds reported $111M of ProQR Therapeutics stock for Q4 2020, down 17% quarter-over-quarter.
  • 14 funds opened new ProQR Therapeutics positions in Q4 2020 and 10 closed out, a net change of +4 holders.
  • The largest ProQR Therapeutics buyer in Q4 2020 was Morgan Stanley, an estimated $3.37M added.
  • The largest ProQR Therapeutics seller in Q4 2020 was Aquilo Capital Management, an estimated $10.9M sold.

Based on aggregated 13F filings for Q4 2020.